Skip to search formSkip to main contentSkip to account menu

ISF 2405

Known as: ISF-2405 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Pyridazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Inhibitory effects of cadralazine and its metabolite, ISF-2405, on contractions and the level of cytosolic Ca2+ in vascular smooth muscle.
1988
1988
Effects of cadralazine on contractions induced by Ca2+ and norepinephrine in isolated rabbit aortic strips.
Antagonistic effects of the new antihypertensive agent cadralazine (ethyl(+/-)-6-[ethyl(2-hydroxypropyl)-amino]-3… 
1988
1988
Pharmacokinetics of an active cadralazine metabolite in plasma and blood vessels of spontaneously hypertensive rats.
The plasma and blood vessel (aorta and mesenteric artery) levels of (+/-)-6-[ethyl(2-hydroxypropyl)amino]-3-hydrazinopyridazine… 
1988
1988
Effects of cadralazine on contractions induced by norepinephrine, serotonin, angiotensin II and K+ in rabbit aortic and renal arterial strips.
Antagonistic effects of the new antihypertensive agent cadralazine (ethyl(+/-)-6-[ethyl(2-hydroxypropyl)-amino]-3… 
1987
1987
Determination of ISF-2405, an active metabolite of cadralazine, in plasma and tissues by radioimmunoassay.
A radioimmunoassay has been developed which makes possible sensitive and specific determination of an active metabolite of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)